Bain utilizza i cookie per migliorare la funzionalità e le prestazioni di questo sito. Ulteriori informazioni in merito si trovano nella nostra Informativa sulla Privacy. Continuando a navigare su questo sito, acconsenti all'uso dei cookie.

CNBC

Health-care companies are on a deal spree and aren't likely to stop anytime soon

Health-care companies are on a deal spree and aren't likely to stop anytime soon

Corporate health-care deal value surged 27 percent last year, according to a new report from Bain & Company.

  • aprile 13, 2018
  • Tempo di lettura min.

CNBC

Health-care companies are on a deal spree and aren't likely to stop anytime soon

Corporate deal value surged to $332 billion last year, up 27 percent from $261 billion in 2016, though still below the peak of $432 billion in 2015, according to a new report from consulting firm Bain & Company.

Three mega-mergers, defined as those worth more than $20 billion, accounted for more than one-third of the total. Still, the number of deals globally increased 16 percent last year from the year before at 3,099.

Shareholders are looking for returns, cash is looking for a home, and debt is still rather cheap, making the overall market favorable for mergers and acquisitions, said Dale Stafford, who leads Bain's mergers and acquisitions practice in the Americas. Specifically in health care, he said, pressure on companies to lower costs is making deals attractive.

Read the full article on CNBC here.